Jupiros 5 Tablet contains Rosuvastatin 5 mg, a potent lipid-lowering agent belonging to the statin class of medications. It is primarily indicated for the treatment of hypercholesterolemia and mixed dyslipidemia to reduce elevated levels of total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglycerides, while increasing high-density lipoprotein cholesterol (HDL-C). Rosuvastatin acts by selectively inhibiting HMG-CoA reductase, the rate-limiting enzyme in cholesterol biosynthesis, leading to decreased cholesterol production and increased clearance of LDL particles from the bloodstream. Jupiros 5 is prescribed to reduce the risk of cardiovascular events such as myocardial infarction, stroke, and the need for revascularization procedures in patients with established coronary artery disease or those at high risk due to multiple risk factors. The recommended dosage is individualized based on patient response and lipid levels, with 5 mg serving as a starting dose for patients requiring moderate lipid reduction or those with increased sensitivity to statins. Common adverse effects may include headache, myalgia, and gastrointestinal disturbances, while rare but serious effects such as myopathy and hepatotoxicity warrant regular monitoring of liver enzymes and creatine kinase levels. Jupiros 5 should be used under medical supervision, with attention to contraindications including active liver disease and pregnancy.